Rallybio Corporation (RLYB) Q1 2026 Earnings
Rallybio Corporation reported Q1 2026 revenue of $212.0K (+0.0% YoY). Diluted EPS came in at $-1.46 (-595.2% YoY), missed the $-1.20 consensus by $0.26.
Financial Snapshot
Trailing eight quarters through Q1 2026
Q1 2026 Earnings FAQ
Common questions about Rallybio Corporation's Q1 2026 earnings report.
Rallybio Corporation (RLYB) reported Q1 2026 earnings on May 13, 2026 before market open.
Rallybio Corporation reported revenue of $212.0K and diluted EPS of $-1.46 for Q1 2026.
Revenue beat the consensus estimate of $212.0K by -. EPS missed the consensus estimate of $-1.20 by $0.26.
Compared to the same quarter a year prior, revenue grew 0.0% from $212.0K a year earlier and diluted EPS declined 595.2% from $-0.21.
You can read the 10-Q periodic report (0001628280-26-034580) directly on SEC EDGAR. The filing index links above go to sec.gov.